Medication-assisted treatment for opioid use disorders in correctional settings: an ethics review
Saved in:
Ludwig, A.S., Peters, R.H., Medication-assisted treatment for opioid use disorders in correctional settings: an ethics review. International Journal of Drug Policy, vol. 25, n. 6, 2014, p.1041-1045.
Ref.
500462
Location:
SIIS R.1114 Archivo
Palabras clave:
Drogodependencias, Drogas ilegales, Opiáceos, Tratamiento médico, Delincuencia, Prisión, Programas de mantenimiento, Metadona, Buprenorfina, Reducción de daños, Ética
Drogodependencias, Drogas ilegales, Opiáceos, Tratamiento médico, Delincuencia, Prisión, Programas de mantenimiento, Metadona, Buprenorfina, Reducción de daños, Ética
Similar Items: Medication-assisted treatment for opioid use disorders in correctional settings: an ethics review
- Compliance with buprenorphine medication-assisted treatment and relapse to opioid use
- ETHICAL AND HUMAN RIGHTS IMPERATIVES TO ENSURE MEDICATION-ASSISTED TREATMENT FOR OPIOID DEPENDENCE IN PRISONS AND PRE-TRIAL DETENTION
- Non-prescribed use of opioid substitution medication: Patterns and trends in sub-populations of opioid users in Germany
- The effectiveness of opioid maintenance treatment in prison settings: A systematic review
- Medication-assisted treatment of opioid dependence. A review of the evidence
- Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review